FullerR. Probiotics in man and animals. J Appl Bacteriol. 1989;66(5):365-378.
2.
QuigleyEM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis. 2007;8(1):2-7.
3.
QuigleyEMBytzerPJonesRMearinF. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis. 2006;38(10):717-723.
4.
QuigleyEMFlourieB. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007;19(3):166-172.
5.
O’MahonyLMcCarthyJKellyP. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541-551.
6.
WhorwellPJAltringerLMorelJ. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581-1590.
7.
GawronskaADziechciarzPHorvathASzajewskaH. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007;25(2):177-184.
8.
KajanderKHatakkaKPoussaTFarkkilaMKorpelaR. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther. 2005;22(5):387-394.
9.
GuslandiMMezziGSorghiMTestoniPA. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci. 2000;45(7):1462-1464.
10.
KimHJVazquez RoqueMICamilleriM. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005;17(5):687-696.
11.
GuyonnetDChassanyODucrotteP. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 2007;26(3):475-486.
12.
KajanderKKrogius-KurikkaLRinttilaTKarjalainenHPalvaAKorpelaR. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26(3):463-473.
13.
GhoshalUCParkHGweeKA. Bugs and irritable bowel syndrome: the good, the bad and the ugly. J Gastroenterol Hepatol. 2010;25(2):244-251.
14.
MoayyediPFordACTalleyNJ. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-332.
15.
McFarlandLVDublinS. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol. 2008;14(17):2650-2661.
16.
McFarlandLV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis. 2007;5(2):97-105.
TungJMDolovichLRLeeCH. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Can J Gastroenterol. 2009;23(12):817-821.
19.
PillaiANelsonR. Probiotics for treatment of Clostridium difficile–associated colitis in adults. Cochrane Database Syst Rev. 2008;(1):CD004611.
20.
BibiloniRFedorakRNTannockGW. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005;100(7):1539-1546.
21.
MieleEPascarellaFGiannettiEQuagliettaLBaldassanoRNStaianoA. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104(2):437-443.
22.
SoodAMidhaVMakhariaGK. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 2009;7(11):1202-1209, 1209.e1.
23.
TursiA. Balsalazide plus high-potency probiotic preparation (VSL#3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon. J Clin Gastroenterol. 2008;42(suppl 3, pt 1):S119-S122.
24.
SangLXChangBZhangWLWuXMLiXHJiangM. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterol. 2010;16(15):1908-1915.
25.
McFarlandLV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18): 2202-2222.
26.
GionchettiPRizzelloFVenturiA. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119(2):305-309.
27.
MimuraTRizzelloFHelwigU. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53(1):108-114.
28.
ElahiBNikfarSDerakhshaniSVafaieMAbdollahiM. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci. 2008;53(5):1278-1284.
